Afghanistan vs Africa (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Africa (WHO region)
96.0%
in 2024
Afghanistan rank
1st
Africa (WHO region) rank
2nd
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Africa (WHO region)
How they compare
Afghanistan currently reports 100.0% against 96.0% in Africa (WHO region), a difference of 4.0%.
The two have swapped places 2 times across 14 shared years of data; in 2009 it was Afghanistan ahead.
Afghanistan ranks 1st and Africa (WHO region) ranks 2nd of 144 countries.
Afghanistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Africa (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 36.0% | 64.0% | Afghanistan |
| 2010s | 78.8% | 74.1% | 4.6% | Afghanistan |
| 2020s | 100.0% | 93.2% | 6.8% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Africa (WHO region)?
- Afghanistan, at 100.0% against 96.0% in Africa (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Africa (WHO region)?
- 4.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Africa (WHO region)?
- 14 years are reported by both, from 2009 to 2024.
- How do Afghanistan and Africa (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Africa (WHO region) ranks 2nd of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.